Bernard Bénichou

Identification and characterization of a spinal muscular atrophy-determining gene

Suzie Lefebvre, Lydie Bürglen, Sophie Reboullet et al. · Cell · 1995 · 3.9K citations · Full text

Genetics, Gene Characterization, Molecular Genetics +3

De Novo and Inherited Deletions of the 5q13 Region in Spinal Muscular Atrophies

Judith Melki, Suzie Lefebvre, Lydie Bürglen et al. · Science · 1994 · 316 citations

Rare Diseases, Developmental Biology, Inherited Deletions +15

Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis.

Bernard Bénichou, Jack L. Strominger · Proceedings of the National Academy of Sciences · 1991 · 126 citations · Full text

Histocompatibility, Complementation Analysis, Genetics +22

A retrospective analysis of the potential impact of IgG antibodies to agalsidase β on efficacy during enzyme replacement therapy for Fabry disease

Bernard Bénichou, Sunita Goyal, Crystal Sung et al. · Molecular Genetics and Metabolism · 2008 · 102 citations

Potential Impact, Autoimmune Disease, Enzyme Replacement Therapy +5

Mapping of X-Linked Myxomatous Valvular Dystrophy to Chromosome Xq28

Florence Kyndt, Jean‐Jacques Schott, Jean‐Noël Trochu et al. · The American Journal of Human Genetics · 1998 · 100 citations · Full text

Mendelian Disorder, Cytogenetics, Genetic Disorder +5